Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Company
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.

Number of employees : 99 412 people.
Sales per Business
20192020Delta
Pharmaceuticals25 708.0071.2%25 674.0071.2% -0.13%
Vaccines5 731.0015.9%5 973.0016.6% +4.22%
Consumer Healthcare4 687.0013%4 394.0012.2% -6.25%
EUR in Million
Sales per region
2020
United States13 465.0037.4%
Rest of the World7 759.0021.5%
Europe6 928.0019.2%
China2 454.006.8%
France2 223.006.2%
Japan1 735.004.8%
Brazil836.002.3%
Russia641.001.8%
EUR in Million
Managers
Name Title Age Since
Paul Hudson Chief Executive Officer & Director 53 2019
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President 56 2018
John Reed EVP & Global Head-Research & Development 62 -
Nestle Frank Global Head-Immunology Therapeutic Research Area - 2016
Dietmar Berger Chief Medical Officer & Global Head-Development - -
Serge Weinberg Chairman 70 2015
Carole Piwnica Independent Director 63 2011
Fabienne Lecorvaisier Independent Director 58 2013
Patrick Kron Independent Director 67 2014
Diane D. Souza Independent Director 68 2016
Members of the board
Name Title Age Since
Serge Weinberg Chairman 70 2015
Carole Piwnica Independent Director 63 2011
Fabienne Lecorvaisier Independent Director 58 2013
Patrick Kron Independent Director 67 2014
Diane D. Souza Independent Director 68 2016
Thomas C. Südhof, Dr. Independent Director 65 2016
Melanie Georgina Lee, Dr. Independent Director 62 2017
Bernard Charlès Independent Director 64 2017
Marion Palme Director 38 2017
Christian Senectaire Director 56 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,258,971,738 1,111,530,239 88.3% 8,281,185 0.7% 88.3%
Shareholders
NameEquities%
L'Oréal S.A. 118,227,307 9.38%
Norges Bank Investment Management 28,276,296 2.24%
The Vanguard Group, Inc. 27,209,381 2.16%
Plan d'Epargne Entreprise Sanofi Synthelabo 22,686,564 1.80%
Dodge & Cox 20,294,609 1.61%
Fidelity Management & Research Co. LLC 16,809,976 1.33%
Amundi Asset Management SA (Investment Management) 13,688,633 1.09%
FIL Investment Advisors (UK) Ltd. 11,855,499 0.94%
Lyxor International Asset Management SAS 11,813,021 0.94%
BlackRock Advisors (UK) Ltd. 10,799,776 0.86%
Holdings
NameEquities%Valuation
SANOFI INDIA LIMITED (500674) 13,909,587 60.4% 1,478,508,283 USD
SANOFI (SAN) 10,039,754 0.80% 1,067,565,897 USD
REGENERON PHARMACEUTICALS (REGN) 279,766 0.27% 140,562,831 USD
TRANSLATE BIO, INC. (TBIO) 4,884,434 6.49% 87,968,656 USD
LAVA THERAPEUTICS B.V. (LVTX) 1,919,455 7.57% 21,785,814 USD
INOZYME PHARMA, INC. (INZY) 520,125 2.21% 8,509,245 USD
COGENT BIOSCIENCES, INC. (COGT) 210,512 0.55% 1,823,034 USD
QUALIGEN THERAPEUTICS, INC. (QLGN) 79,209 0.27% 151,289 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Compartiment A
- CAC 40 / CAC 40 ESG, CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, Euro Stoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, SBF 120, Stoxx Europe 50, STOXX Europe 600, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
Company contact information
Sanofi
54 Rue la Boétie
FR-75008 Paris

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
web site : http://www.sanofi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sanofi
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
SANOFI11.91%131 827
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG11.02%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG0.20%207 246
ABBVIE INC.10.30%199 548
MERCK & CO., INC.-6.44%195 475
NOVO NORDISK A/S31.37%188 446
ASTRAZENECA PLC15.78%155 197
BRISTOL-MYERS SQUIBB COMPANY10.17%149 020
AMGEN INC.7.74%139 433
GLAXOSMITHKLINE PLC5.51%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.32%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619
EISAI CO., LTD.24.00%30 450